Please enable JavaScript to continue using this application.

Compare $IMRX vs $QTTB | Chartloom

Compare

$IMRX vs $QTTB

Immuneering Corp · Q32 Bio Inc

IMRX

Immuneering Corp

QTTB

Q32 Bio Inc

Compare $IMRX vs $QTTB

Comparing Immuneering Corp and Q32 Bio Inc

IMRXImmuneering Corp

QTTBQ32 Bio Inc

IMRXImmuneering Corp

Market cap

$255M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-40.5%

52W performance

-39.4%

FCF yield

-22.4%

QTTBQ32 Bio Inc

Market cap

$248M

P/E (TTM)

8.22x

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

142.4%

52W performance

178.9%

FCF yield

-8.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

IMRX

QTTB

Detailed metrics comparison

IMRX

Immuneering Corp

QTTB

Q32 Bio Inc

Market Cap

IMRX$255M

QTTB$248M

Enterprise Value

IMRX$214M

QTTB$142M

Price

IMRX$3.94

QTTB$8.34

P/E Ratio

IMRXN/A

QTTB8.22x

P/S Ratio

IMRX526.64x

QTTB4.62x

EV/Sales

IMRX443.99x

QTTB2.64x

EV/EBITDA

IMRX0.00x

QTTB3.69x

P/B Ratio

IMRX1.38x

QTTB2.31x

P/FCF Ratio

IMRXN/A

QTTBN/A

EV/FCF

IMRX-3.75x

QTTB-7.16x

PEG Ratio

IMRXN/A

QTTBN/A

Forward P/E (NTM)

IMRXN/A

QTTBN/A

Forward P/S (NTM)

IMRXN/A

QTTBN/A

Revenue (TTM)

IMRX$0

QTTB$54M

Revenue Growth (YoY)

IMRXN/A

QTTBN/A

Forward Rev Growth

IMRX100.5%

QTTB215.1%

Gross Margin (TTM)

IMRX28.0%

QTTB0.0%

Operating Margin (TTM)

IMRX0.0%

QTTB85.4%

EBITDA Margin (TTM)

IMRX0.0%

QTTB71.6%

Net Margin (TTM)

IMRX0.0%

QTTB93.7%

FCF Margin (TTM)

IMRXN/A

QTTB-36.9%

Net Income (TTM)

IMRX$-57M

QTTB$50M

FCF (TTM)

IMRX$-57M

QTTB$-20M

EPS (TTM)

IMRX-$0.89

QTTB$0.00

ROE (TTM)

IMRX-2715.0%

QTTB137.4%

ROA (TTM)

IMRX-2574.0%

QTTB45.1%

ROIC (TTM)

IMRX-2715.0%

QTTB111.6%

Cash

IMRX$41M

QTTB$106M

Debt

IMRX$0

QTTB$0

Net Cash/Debt

IMRX$41M

QTTB$106M

Current Ratio (TTM)

IMRX19.47x

QTTB20.30x

Quick Ratio (TTM)

IMRX18.47x

QTTB19.80x

Debt/Equity (TTM)

IMRX0.00x

QTTB2.29x

Debt/Assets (TTM)

IMRX0.0%

QTTB0.0%

Interest Coverage (TTM)

IMRXN/A

QTTBN/A

Net Debt/EBITDA (TTM)

IMRX0.00x

QTTB0.00x

Beta

IMRX0.34

QTTB0.50

52W Performance

IMRX-39.4%

QTTB178.9%

YTD Performance

IMRX-40.5%

QTTB142.4%

% from 52W High

IMRX-53.5%

QTTB-64.6%

% from 52W Low

IMRX9.4%

QTTB337.8%

Asset Turnover (TTM)

IMRX0.00x

QTTB0.87x

FCF Yield (TTM)

IMRX-22.4%

QTTB-8.0%

Earnings Yield (TTM)

IMRX-22.5%

QTTB20.3%

Dividend Yield (TTM)

IMRXN/A

QTTBN/A

Rule of 40

IMRX0.0

QTTB-36.9

EV/GP/RG

IMRXN/A

QTTBN/A

Ticker research

View IMRX research View QTTB research

Metric	IMRX Immuneering Corp	QTTB Q32 Bio Inc
Market & Valuation
Market Cap	$255M	$248M
Enterprise Value	$214M	$142M
Price	$3.94	$8.34
P/E Ratio	N/A	8.22x
P/S Ratio	526.64x	4.62x
EV/Sales	443.99x	2.64x
EV/EBITDA	0.00x	3.69x
P/B Ratio	1.38x	2.31x
P/FCF Ratio	N/A	N/A
EV/FCF	-3.75x	-7.16x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$54M
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	100.5%	215.1%
Profitability
Gross Margin (TTM)	28.0%	0.0%
Operating Margin (TTM)	0.0%	85.4%
EBITDA Margin (TTM)	0.0%	71.6%
Net Margin (TTM)	0.0%	93.7%
FCF Margin (TTM)	N/A	-36.9%
Net Income (TTM)	$-57M	$50M
FCF (TTM)	$-57M	$-20M
EPS (TTM)	-$0.89	$0.00
ROE (TTM)	-2715.0%	137.4%
ROA (TTM)	-2574.0%	45.1%
ROIC (TTM)	-2715.0%	111.6%
Financial Health
Cash	$41M	$106M
Debt	$0	$0
Net Cash/Debt	$41M	$106M
Current Ratio (TTM)	19.47x	20.30x
Quick Ratio (TTM)	18.47x	19.80x
Debt/Equity (TTM)	0.00x	2.29x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.34	0.50
52W Performance	-39.4%	178.9%
YTD Performance	-40.5%	142.4%
% from 52W High	-53.5%	-64.6%
% from 52W Low	9.4%	337.8%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.87x
FCF Yield (TTM)	-22.4%	-8.0%
Earnings Yield (TTM)	-22.5%	20.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-36.9
EV/GP/RG	N/A	N/A
Ticker research	View IMRX research	View QTTB research

Valuation

P/E Ratio

QTTB

8.22x

P/S Ratio

QTTB

4.62x

IMRX

526.64x

EV/FCF

QTTB

-7.16x

IMRX

-3.75x

Growth & revenue

Forward Revenue Growth

QTTB

215.1%

IMRX

100.5%

Profitability & performance

Gross Margin

IMRX

28.0%

QTTB

0.0%

ROE

QTTB

137.4%

IMRX

-2715.0%

FCF Yield %

QTTB

-8.0%

IMRX

-22.4%

52-Week Performance

QTTB

178.9%

IMRX

-39.4%

Detailed metrics comparison

IMRX

Immuneering Corp

QTTB

Q32 Bio Inc

Market Cap

IMRX$255M

QTTB$248M

Enterprise Value

IMRX$214M

QTTB$142M

Price

IMRX$3.94

QTTB$8.34

P/E Ratio

IMRXN/A

QTTB8.22x

P/S Ratio

IMRX526.64x

QTTB4.62x

EV/Sales

IMRX443.99x

QTTB2.64x

EV/EBITDA

IMRX0.00x

QTTB3.69x

P/B Ratio

IMRX1.38x

QTTB2.31x

P/FCF Ratio

IMRXN/A

QTTBN/A

EV/FCF

IMRX-3.75x

QTTB-7.16x

PEG Ratio

IMRXN/A

QTTBN/A

Forward P/E (NTM)

IMRXN/A

QTTBN/A

Forward P/S (NTM)

IMRXN/A

QTTBN/A

Revenue (TTM)

IMRX$0

QTTB$54M

Revenue Growth (YoY)

IMRXN/A

QTTBN/A

Forward Rev Growth

IMRX100.5%

QTTB215.1%

Gross Margin (TTM)

IMRX28.0%

QTTB0.0%

Operating Margin (TTM)

IMRX0.0%

QTTB85.4%

EBITDA Margin (TTM)

IMRX0.0%

QTTB71.6%

Net Margin (TTM)

IMRX0.0%

QTTB93.7%

FCF Margin (TTM)

IMRXN/A

QTTB-36.9%

Net Income (TTM)

IMRX$-57M

QTTB$50M

FCF (TTM)

IMRX$-57M

QTTB$-20M

EPS (TTM)

IMRX-$0.89

QTTB$0.00

ROE (TTM)

IMRX-2715.0%

QTTB137.4%

ROA (TTM)

IMRX-2574.0%

QTTB45.1%

ROIC (TTM)

IMRX-2715.0%

QTTB111.6%

Cash

IMRX$41M

QTTB$106M

Debt

IMRX$0

QTTB$0

Net Cash/Debt

IMRX$41M

QTTB$106M

Current Ratio (TTM)

IMRX19.47x

QTTB20.30x

Quick Ratio (TTM)

IMRX18.47x

QTTB19.80x

Debt/Equity (TTM)

IMRX0.00x

QTTB2.29x

Debt/Assets (TTM)

IMRX0.0%

QTTB0.0%

Interest Coverage (TTM)

IMRXN/A

QTTBN/A

Net Debt/EBITDA (TTM)

IMRX0.00x

QTTB0.00x

Beta

IMRX0.34

QTTB0.50

52W Performance

IMRX-39.4%

QTTB178.9%

YTD Performance

IMRX-40.5%

QTTB142.4%

% from 52W High

IMRX-53.5%

QTTB-64.6%

% from 52W Low

IMRX9.4%

QTTB337.8%

Asset Turnover (TTM)

IMRX0.00x

QTTB0.87x

FCF Yield (TTM)

IMRX-22.4%

QTTB-8.0%

Earnings Yield (TTM)

IMRX-22.5%

QTTB20.3%

Dividend Yield (TTM)

IMRXN/A

QTTBN/A

Rule of 40

IMRX0.0

QTTB-36.9

EV/GP/RG

IMRXN/A

QTTBN/A

Ticker research

View IMRX research View QTTB research

Metric	IMRX Immuneering Corp	QTTB Q32 Bio Inc
Market & Valuation
Market Cap	$255M	$248M
Enterprise Value	$214M	$142M
Price	$3.94	$8.34
P/E Ratio	N/A	8.22x
P/S Ratio	526.64x	4.62x
EV/Sales	443.99x	2.64x
EV/EBITDA	0.00x	3.69x
P/B Ratio	1.38x	2.31x
P/FCF Ratio	N/A	N/A
EV/FCF	-3.75x	-7.16x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$54M
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	100.5%	215.1%
Profitability
Gross Margin (TTM)	28.0%	0.0%
Operating Margin (TTM)	0.0%	85.4%
EBITDA Margin (TTM)	0.0%	71.6%
Net Margin (TTM)	0.0%	93.7%
FCF Margin (TTM)	N/A	-36.9%
Net Income (TTM)	$-57M	$50M
FCF (TTM)	$-57M	$-20M
EPS (TTM)	-$0.89	$0.00
ROE (TTM)	-2715.0%	137.4%
ROA (TTM)	-2574.0%	45.1%
ROIC (TTM)	-2715.0%	111.6%
Financial Health
Cash	$41M	$106M
Debt	$0	$0
Net Cash/Debt	$41M	$106M
Current Ratio (TTM)	19.47x	20.30x
Quick Ratio (TTM)	18.47x	19.80x
Debt/Equity (TTM)	0.00x	2.29x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.34	0.50
52W Performance	-39.4%	178.9%
YTD Performance	-40.5%	142.4%
% from 52W High	-53.5%	-64.6%
% from 52W Low	9.4%	337.8%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.87x
FCF Yield (TTM)	-22.4%	-8.0%
Earnings Yield (TTM)	-22.5%	20.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-36.9
EV/GP/RG	N/A	N/A
Ticker research	View IMRX research	View QTTB research